Implementation of patient-reported outcomes in routine medical care
G VELIKOVA - American Society of Clinical Oncology Educational …, 2018 - ascopubs.org
There is increasing interest to integrate collection of patient-reported outcomes (PROs) in
routine practice to enhance clinical care. Multiple studies show that systematic monitoring of …
routine practice to enhance clinical care. Multiple studies show that systematic monitoring of …
[HTML][HTML] Prevalence of fatigue in patients with cancer: a systematic review and meta-analysis
M Al Maqbali, M Al Sinani, Z Al Naamani… - Journal of pain and …, 2021 - Elsevier
Context Fatigue is a particularly common and troubling symptom that has a negative impact
on quality of life throughout all phases of treatment and stages of the illness among patients …
on quality of life throughout all phases of treatment and stages of the illness among patients …
[HTML][HTML] The role of patient-reported outcome measures in the continuum of cancer clinical care: ESMO Clinical Practice Guideline
Highlights•This ESMO Guideline provides key recommendations on the role of PROMs
during the care of patients with cancer.•It covers the use of PROMs in patients with cancer …
during the care of patients with cancer.•It covers the use of PROMs in patients with cancer …
Phase III randomized controlled trial of eRAPID: eHealth intervention during chemotherapy
K Absolom, L Warrington, E Hudson… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE Electronic patient self-Reporting of Adverse-events: Patient Information and
aDvice (eRAPID) is an online eHealth system for patients to self-report symptoms during …
aDvice (eRAPID) is an online eHealth system for patients to self-report symptoms during …
[HTML][HTML] Thresholds for clinical importance were established to improve interpretation of the EORTC QLQ-C30 in clinical practice and research
Objective The objective of this study was to establish thresholds for clinical importance
(TCIs) for the five functioning and nine symptom scales of the European Organisation for …
(TCIs) for the five functioning and nine symptom scales of the European Organisation for …
[PDF][PDF] Validity and reliability of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO …
Importance To integrate the patient perspective into adverse event reporting, the National
Cancer Institute developed a patient-reported outcomes version of the Common …
Cancer Institute developed a patient-reported outcomes version of the Common …
Safety and tolerability of PD‐1/PD‐L1 inhibitors compared with chemotherapy in patients with advanced cancer: a meta‐analysis
TF Nishijima, SS Shachar, KA Nyrop, HB Muss - The oncologist, 2017 - academic.oup.com
Background Compared with chemotherapy, significant improvement in survival outcomes
with the programmed death receptor‐1 (PD‐1) inhibitors nivolumab and pembrolizumab and …
with the programmed death receptor‐1 (PD‐1) inhibitors nivolumab and pembrolizumab and …
Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms
PG Kluetz, A Slagle, EJ Papadopoulos… - Clinical Cancer …, 2016 - AACR
Cancer clinical trials have relied on overall survival and measures of tumor growth or
reduction to assess the efficacy of a drug. However, benefits are often accompanied by …
reduction to assess the efficacy of a drug. However, benefits are often accompanied by …
Composite grading algorithm for the national cancer institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)
Background: The Patient-Reported Outcomes version of the Common Terminology Criteria
for Adverse Events is an item library designed for eliciting patient-reported adverse events in …
for Adverse Events is an item library designed for eliciting patient-reported adverse events in …
Patient-reported outcomes in the evaluation of toxicity of anticancer treatments
Symptomatic toxicities associated with anticancer treatments, such as nausea and vomiting,
are frequently underreported by clinicians, even when data are prospectively collected …
are frequently underreported by clinicians, even when data are prospectively collected …